The latest closing stock price for Leap Therapeutics as of September 18, 2024 is 2.88.
An investor who bought $1,000 worth of Leap Therapeutics stock at the IPO in 2017 would have $-963 today, roughly -1 times their original investment - a -33.86% compound annual growth rate over 8 years.
The all-time high Leap Therapeutics stock closing price was 100.10 on April 12, 2018.
The Leap Therapeutics 52-week high stock price is 5.00, which is 73.6% above the current share price.
The Leap Therapeutics 52-week low stock price is 1.24, which is 56.9% below the current share price.
The average Leap Therapeutics stock price for the last 52 weeks is 2.52.
An investor who bought $1,000 worth of Leap Therapeutics stock at the IPO in 2017 would have $-963 today, roughly -1 times their original investment - a -33.86% compound annual growth rate over 8 years.
The all-time high Leap Therapeutics stock closing price was 100.10 on April 12, 2018.
The Leap Therapeutics 52-week high stock price is 5.00, which is 73.6% above the current share price.
The Leap Therapeutics 52-week low stock price is 1.24, which is 56.9% below the current share price.
The average Leap Therapeutics stock price for the last 52 weeks is 2.52.